| |
NGT |
i-IFG |
i-IGT |
IFG/IGT |
NDD |
Known diabetes |
| Men (n=1,429) |
(n=969) |
(n=75) |
(n=147) |
(n=42) |
(n=61) |
(n=135) |
| Hemoglobin |
OR (95% CI) |
OR (95% CI) |
OR (95% CI) |
OR (95% CI) |
OR (95% CI) |
OR (95% CI) |
| a Model 1 |
1.00 |
1.09 (0.81-1.46) |
1.39 (1.11-1.74) |
1.54 (1.04-2.27) |
1.37 (0.99-1.89) |
0.80 (0.64-0.99) |
| b Model 2 |
1.00 |
0.96 (0.70-1.31) |
1.23 (0.97-1.57) |
1.31 (0.86-1.97) |
1.17 (0.83-1.64) |
0.78 (0.62-0.98) |
| Hematocrit |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.06 (0.80-1.42) |
1.30 (1.05-1.62) |
1.35 (0.92-1.96) |
1.35 (0.98-1.85) |
0.77 (0.62-0.96) |
| b Model 2 |
1.00 |
0.95 (0.69-1.29) |
1.16 (0.92-1.47) |
1.16 (0.77-1.73) |
1.18 (0.84-1.64) |
0.75 (0.59-0.94) |
| Platelet count |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.06 (0.84-1.33) |
1.02 (0.86-1.22) |
0.76 (0.53-1.08) |
0.91 (0.70-1.20) |
0.76 (0.62-0.95) |
| b Model 2 |
1.00 |
1.10 (0.87-1.39) |
1.04 (0.86-1.25) |
0.79 (0.55-1.14) |
0.97 (0.74-1.28) |
0.79 (0.64-0.98) |
| Mean platelet volume |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.09 (0.86-1.38) |
0.98 (0.82-1.18) |
1.27 (0.95-1.71) |
1.00 (0.76-1.30) |
1.27 (1.05-1.53) |
| b Model 2 |
1.00 |
1.05 (0.83-1.35) |
0.95 (0.78-1.15) |
1.18 (0.86-1.60) |
0.90 (0.68-1.19) |
1.19 (0.97-1.45) |
| White blood cell count |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.03 (0.78-1.35) |
1.37 (1.16-1.61) |
1.18 (0.85-1.63) |
1.41 (1.16-1.71) |
1.34 (1.13-1.59) |
| b Model 2 |
1.00 |
1.01 (0.74-1.36) |
1.32 (1.11-1.58) |
1.11 (0.77-1.59) |
1.33 (1.07-1.66) |
1.18 (0.98-1.43) |
| Women (n=1,534) |
(n=1,161) |
(n=38) |
(n=168) |
(n=27) |
(n=47) |
(n=93) |
| Hemoglobin |
|
OR (95% CI) |
OR (95% CI) |
OR (95% CI) |
OR (95% CI) |
OR (95% CI) |
| a Model 1 |
1.00 |
1.33 (0.86-2.07) |
1.64 (1.30-2.07) |
2.72 (1.61-4.62) |
1.66 (1.11-2.47) |
1.19 (0.89-1.58) |
| bModel 2 |
1.00 |
1.16 (0.73-1.82) |
1.60 (1.25-2.06) |
2.44 (1.41-4.23) |
1.50 (0.98-2.29) |
1.18 (0.86-1.62) |
| Hematocrit |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.26 (0.83-1.93) |
1.60 (1.28-2.00) |
2.41 (1.44-4.01) |
1.63 (1.11-2.41) |
1.20 (0.90-1.59) |
| b Model 2 |
1.00 |
1.11 (0.71-1.72) |
1.57 (1.23-2.00) |
2.20 (1.29-3.76) |
1.56 (1.02-2.38) |
1.21 (0.88-1.66) |
| Platelet count |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.19 (0.87-1.63) |
0.96 (0.80-1.14) |
0.81 (0.53-1.25) |
1.12 (0.84-1.50) |
0.96 (0.76-1.21) |
| b Model 2 |
1.00 |
1.16 (0.84-1.60) |
0.95 (0.79-1.14) |
0.81 (0.52-1.27) |
1.13 (0.83-1.53) |
1.01 (0.78-1.29) |
| Mean platelet volume |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.12 (0.82-1.54) |
1.10 (0.93-1.29) |
1.19 (0.82-1.72) |
1.10 (0.82-1.47) |
1.26 (1.02-1.55) |
| b Model 2 |
1.00 |
1.11 (0.81-1.52) |
1.09 (0.92-1.29) |
1.16 (0.79-1.70) |
1.06 (0.79-1.44) |
1.18 (0.94-1.48) |
| White blood cell count |
|
|
|
|
|
|
| a Model 1 |
1.00 |
1.37 (0.95-1.98) |
1.51 (1.25-1.82) |
1.70 (1.13-2.55) |
2.19 (1.68-2.84) |
2.07 (1.67-2.57) |
| b Model 2 |
1.00 |
1.16 (0.76-1.76) |
1.56 (1.27-1.91) |
1.54 (0.98-2.41) |
1.87 (1.39-2.52) |
1.84 (1.43-2.38) |
NGT: Normal Glucose Tolerance; i-IFG: Isolated Impaired Fasting Glucose; i-IGT: Isolated Impaired Glucose Tolerance; NDD: Newly Detected Diabetes; Odds ratio (OR) expressed per SD-increment; significant findings are highlighted in bold characters; aModel 1: adjusted for age ; bModel 2: adjusted for age, actual hypertension, regular smoking, physical activity, alcohol intake, total cholesterol, HDL cholesterol, creatinine, and BMI |
